 | Issue navigator |
| |
Infectious Agents and Cancer publishes selected research, proceedings and collections of thematic reviews as supplements. All articles published in supplements are subject to peer review and are free to access online. The journal also publishes supplements containing meeting abstracts.
Contents of Volume 4 Suppl 2
Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research
Meeting abstracts  A single PDF containing all abstracts in this Supplement is available here.
from 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research
Bethesda, MD, USA. 6 7 October 2008 Publication of this supplement was made possible with support from the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health.
|
Oral presentation
Development and application of a real time PCR assay for detection and quantification of merkel cell virus (MCV) in archived formalin fixed paraffin embedded tissue samples of merkel cell carcinoma and other cancers
R Modali, J Goedert, E Engels, LW Ayers, K Bhatia
Infectious Agents and Cancer 2009, 4(Suppl 2):O1 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Incidence and risk factors of HIV-associated non-Hodgkin-lymophma in the era combined anti-retroviral therapy. A European multi-cohort study
J Bohlius
Infectious Agents and Cancer 2009, 4(Suppl 2):O2 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (19982006)
M Bruyand, R Thiebaut, F Dabis, S Lawson-Ayayi, P Joly, AJ Sasco, P Mercie, JL Pellegrin, S Geffard, D Neau, P Morlat, G Chene, F Bonnet, the Goupe D'Epidemiologie Clinique Du Sida En Aquitaine (GECSA)
Infectious Agents and Cancer 2009, 4(Suppl 2):O3 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
A population-based study of how children are exposed to saliva in Africa: implications for KSHV transmission
LM Butler, S Mzolo, A Mosam, JN Martin
Infectious Agents and Cancer 2009, 4(Suppl 2):O4 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy
HQ Nguyen, F Okuku, F Ssewankambo, AS Magaret, C Johnston, A Wald, A Kambugu, L Corey, J Orem, C Casper
Infectious Agents and Cancer 2009, 4(Suppl 2):O5 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma
GM Clifford, M Rickenbach, S Franceschi, the Swiss HIV Cohort Study
Infectious Agents and Cancer 2009, 4(Suppl 2):O6 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
A Bhatt, P Bhende, B Damania
Infectious Agents and Cancer 2009, 4(Suppl 2):O7 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
High resolution profiling of DNA copy number and gene expression changes in AIDS-related lymphoma
KE Deffenbacher, Z Liu, J Iqbal, H Geng, K Fu, WC Chan
Infectious Agents and Cancer 2009, 4(Suppl 2):O8 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab
K Dunleavy, RF Little, AS Wayne, N Grant, S Pittaluga, ES Jaffe, S Steinberg, R Yarchoan, J Carrasquillo, J Janik, WH Wilson
Infectious Agents and Cancer 2009, 4(Suppl 2):O9 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Epidemiology of non-keratinocytic skin cancers among persons with AIDS in the United States
E Lanoy, GM Dores, MM Madeleine, JR Toro, JF Fraumeni, EA Engels
Infectious Agents and Cancer 2009, 4(Suppl 2):O10 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
HIV induces the expression of activation-induced cytidine deaminase (AICDA) in B cells through a direct interaction between virion-associated CD40L and CD40
M Epeldegui, S Kitchen, J De La Cruz, J Zack, O Martinez-Maza
Infectious Agents and Cancer 2009, 4(Suppl 2):O11 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses
P Gasperini, G Tosato
Infectious Agents and Cancer 2009, 4(Suppl 2):O12 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
An invasion mechanism for human papillomavirus related cancers: HPV 16 E6 degrades PTPN13 allowing enhanced map kinase signaling
AC Hoover, GL Strand, PN Nowicki, ME Anderson, AJ Klingelhutz, AD Bossler, JH Lee
Infectious Agents and Cancer 2009, 4(Suppl 2):O13 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)
A Krishnan, J Zaia, J Alvarnas, N Kogut, J Cai, A Nademanee, J Palmer, N Tsai, SJ Forman
Infectious Agents and Cancer 2009, 4(Suppl 2):O14 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study
E Lanoy, JP Spano, F Bonnet, F Boué, C Katlama, D Costagliola
Infectious Agents and Cancer 2009, 4(Suppl 2):O15 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer
PW Nowicki, WC Spanos, DW Lee, ME Anderson, AJ Hoover, JH Lee
Infectious Agents and Cancer 2009, 4(Suppl 2):O16 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation
JN Martin, M Laker, A Kambugu, D Janka, J Orem, A Mwaka, T Maurer, EK Mbidde
Infectious Agents and Cancer 2009, 4(Suppl 2):O17 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Preliminary findings on cancer incidence in HIV-infected persons from six countries in Central and South America and the Caribbean
DR Masys, F Fang, I Ye, V Fink, E Gotuzzo, D Padgett, JW Pape, C Cortes, M Bacon, M Schechter
Infectious Agents and Cancer 2009, 4(Suppl 2):O18 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Profiling of cellular and viral microRNAs in Kaposi sarcoma and viral-associated lymphoma
DP Dittmer, AJ O'Hara, L Wang, BJ Dezube, W Harrington Jr, B Damania
Infectious Agents and Cancer 2009, 4(Suppl 2):O19 (17 June 2009)
[Abstract] [Full text] [PDF]
Oral presentation
Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD)
R Yarchoan, D O'Mahony, K Aleman, KM Wyvill, D Whitby, W Bernstein, S Pittaluga, ES Jaffe, G Tosato, DA Davis, SM Steinberg, RF Little
Infectious Agents and Cancer 2009, 4(Suppl 2):O20 (17 June 2009)
[Abstract] [Full text] [PDF]
| |
|   |
